Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hyperuricemia and gout

The Journal of Family Practice

|May 1, 1982

Summary

This summary is machine-generated.

Hyperuricemia and acute gout remain common. Most hyperuricemia patients are under-excreters and often require no treatment, while over-producers may need individualized therapy for gout and kidney stones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aminoglycosides: once-daily dosing regimen.

American family physician·1996

Same author

Principles of drug therapy in geriatric patients.

American family physician·1992

Same author

Alternative first-line therapies in geriatric hypertension.

Geriatrics·1989

Same author

Atrial fibrillation.

The Journal of family practice·1986

Same author

Digitalis glycosides.

American family physician·1983

Same author

Type I Hyperlipidemia.

American family physician·1983

Same journal

Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?

The Journal of family practice·2023

Same journal

Preventing RSV in children and adults: A vaccine update.

The Journal of family practice·2023

Same journal

Essential oils: How safe? How effective?

The Journal of family practice·2023

Same journal

51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?

The Journal of family practice·2023

Same journal

Renewing the dream.

The Journal of family practice·2023

Same journal

55-year-old woman • Myalgias and progressive symmetrical proximal weakness • History of unilateral renal agenesis, type 2 diabetes, and hyperlipidemia • Dx?

The Journal of family practice·2023

See all related articles

Area of Science:

Nephrology
Rheumatology
Internal Medicine

Background:

Chronic tophaceous gout is rare, but hyperuricemia and acute gout are prevalent.
Most hyperuricemia cases involve under-excretion, often drug-induced.
Asymptomatic hyperuricemia typically does not cause renal issues or stones in under-excreters.

Purpose of the Study:

To review the management of hyperuricemia and acute gout.
To differentiate treatment strategies based on uric acid production and excretion.
To highlight risks associated with specific treatments like allopurinol.

Main Methods:

Literature review and clinical practice guidelines synthesis.
Analysis of patient subgroups based on uric acid metabolism (over-producers vs. under-excreters).

Related Experiment Videos

Evaluation of treatment options for acute gout and prophylaxis.

Main Results:

Under-excreters with hyperuricemia generally do not require treatment.
Over-producers of uric acid face higher risks of kidney stones (urolithiasis) and need individualized management.
Acute gout responds well to colchicine or indomethacin; newer NSAIDs offer alternatives with fewer GI side effects.
Prophylaxis is indicated for recurrent gout or uric acid stones.
Uricosuric drugs are not recommended for over-producers or those with kidney issues.
Allopurinol hypersensitivity syndrome is a serious, potentially fatal risk.

Conclusions:

Management of hyperuricemia and acute gout requires careful consideration of individual uric acid metabolism and clinical presentation.
Treatment decisions should weigh efficacy against potential adverse effects, particularly with allopurinol.
Preventive strategies are crucial for patients with recurrent gout or a history of uric acid urolithiasis.